Difficulty: Medium
Average Score: 92%
Practice
Pheochromocytoma is a tumor of the adrenal medulla. The tumor results in extraordinary high blood noradrenaline levels. What drug or drug combination can block all of adrenergic receptors and normalize all the signs and symptoms caused by pheochromocytoma?
Correct answer
C
Rationale
The correct answer is C) Phentolamine plus propranolol because it provides a comprehensive approach to managing the signs and symptoms caused by pheochromocytoma.
Phentolamine is a non-selective alpha-adrenergic receptor antagonist that helps counteract the excessive alpha-adrenergic stimulation seen in pheochromocytoma, thereby reducing vasoconstriction and hypertension. Propranolol, a non-selective beta-adrenergic receptor antagonist, complements phentolamine by blocking the effects of beta-adrenergic stimulation, such as tachycardia and palpitations.
Option A) Propranolol alone is not sufficient as it only blocks beta-adrenergic receptors, leaving the alpha-adrenergic receptors still active. Option B) Phentolamine alone may help with alpha-adrenergic effects but does not address the beta-adrenergic effects. Option D) Atropine plus phenylephrine is not an appropriate combination for treating pheochromocytoma as atropine is a muscarinic antagonist and phenylephrine is an alpha-adrenergic agonist, which would exacerbate the symptoms rather than alleviate them.
In an educational context, understanding the mechanism of action of different adrenergic receptor antagonists and their specific roles in managing conditions like pheochromocytoma is crucial for healthcare professionals to provide effective and safe patient care. This question highlights the importance of combining medications with complementary actions to achieve optimal therapeutic outcomes in complex clinical scenarios.
Phentolamine is a non-selective alpha-adrenergic receptor antagonist that helps counteract the excessive alpha-adrenergic stimulation seen in pheochromocytoma, thereby reducing vasoconstriction and hypertension. Propranolol, a non-selective beta-adrenergic receptor antagonist, complements phentolamine by blocking the effects of beta-adrenergic stimulation, such as tachycardia and palpitations.
Option A) Propranolol alone is not sufficient as it only blocks beta-adrenergic receptors, leaving the alpha-adrenergic receptors still active. Option B) Phentolamine alone may help with alpha-adrenergic effects but does not address the beta-adrenergic effects. Option D) Atropine plus phenylephrine is not an appropriate combination for treating pheochromocytoma as atropine is a muscarinic antagonist and phenylephrine is an alpha-adrenergic agonist, which would exacerbate the symptoms rather than alleviate them.
In an educational context, understanding the mechanism of action of different adrenergic receptor antagonists and their specific roles in managing conditions like pheochromocytoma is crucial for healthcare professionals to provide effective and safe patient care. This question highlights the importance of combining medications with complementary actions to achieve optimal therapeutic outcomes in complex clinical scenarios.